FindTrial
Sign In

Clinical Study to Evaluate the Effectiveness of Krishna Mruttika Lepa in Treating Vyanga, with a Focus on Melasma

Randomized controlled clinical study to evaluate the efficacy of krishna mruttika lepa in the management of Vyanga with special refference to Mlasma - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/083721
Enrollment
30
Registered
2025-03-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

None listed

Sponsors

Dr Jasmeen S Akkalkot
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects diagnosed with Melasma chronicity less than 5 years of age. 2.Subjects fulfilling the diagnosed criteria of Melasma with clinical features of VYANGA .

Exclusion criteria

Exclusion criteria: 1 Individuals with hyper pigmentary disorders other than melasma 2 Females on oral contraceptive pills, pregnant women, lactating women 3 Hyperpigmentation since birth 4 individuals with endocrine disorders

Design outcomes

Primary

MeasureTime frame
Significant decrease in melasma pigmentation based on MASI Score. Significant decrease in colour and number of lesions based on the arbitrary grading and fairness meter scale.Timepoint: 0TH Day-First Visit 15TH Day -Second Visit 30TH Day-Third visit 45TH DAY-FOLLOW UP—

Secondary

MeasureTime frame
generation of in depthanalysed data on different aspects of diseaseand its treatment.Timepoint: 45th day-follow up—

Countries

India

Contacts

Public ContactDr Sajitha K

Sri Sri College of Ayurvedic science and research

sajithak96@gmail.com7760987722

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026